<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02600273</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00067757</org_study_id>
    <secondary_id>5P30AI064518</secondary_id>
    <nct_id>NCT02600273</nct_id>
  </id_info>
  <brief_title>Novel Approaches to Reducing Tobacco Related Harm</brief_title>
  <official_title>Novel Approaches to Reducing Tobacco Related Harm Among HIV-Infected Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess initial reactions to alternative nicotine/tobacco
      products among smokers living with HIV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will sample 4 alternative nicotine/tobacco products and provide initial
      reactions to the products.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective effects, as measured by survey</measure>
    <time_frame>within 2 minutes after sampling product(s)</time_frame>
    <description>Satisfaction, acceptability, withdrawal, craving</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk perceptions, as measured by survey</measure>
    <time_frame>Before and within 2 minutes after sampling product(s)</time_frame>
    <description>Risk perceptions of products</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interest and confidence in quitting, as measured by survey</measure>
    <time_frame>within 2 minutes after sampling product(s)</time_frame>
    <description>Interest and confidence in using and purchasing the tested products in the future</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reinforcing properties of product(s), as measured by survey</measure>
    <time_frame>within 2 minutes after sampling product(s)</time_frame>
    <description>Behavioral economics measures (commodity purchase task &amp; cross-price elasticity)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Smoking</condition>
  <condition>Tobacco Smoking Behavior</condition>
  <condition>Cigarette Smoking</condition>
  <arm_group>
    <arm_group_label>Usual brand cigarettes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>During one session, participants will smoke their usual brand cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lower nicotine content cigarettes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During one session, participants will smoke SPECTRUM Research Cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electronic cigarettes 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During one session, participants will use an electronic cigarette with 0 mg/mL nicotine e-liquid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electronic cigarettes 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During one session, participants will use an electronic cigarette with 18 mg/mL nicotine e-liquid</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual brand cigarettes</intervention_name>
    <description>Usual brand cigarettes</description>
    <arm_group_label>Usual brand cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lower nicotine content cigarettes</intervention_name>
    <description>SPECTRUM research cigarettes</description>
    <arm_group_label>Lower nicotine content cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electronic cigarettes 1</intervention_name>
    <description>Electronic cigarette with 0 g/mL e-liquid</description>
    <arm_group_label>Electronic cigarettes 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electronic cigarettes 2</intervention_name>
    <description>Electronic cigarette with 18 g/mL e-liquid</description>
    <arm_group_label>Electronic cigarettes 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. HIV-infected adults age 18 and older currently receiving HIV care

          2. Self-report smoking ≥10 cigarettes/day of a brand delivering &gt;0.5mg nicotine for &gt;2yrs

          3. Have afternoon expired CO concentrations of ≥10ppm or morning urinary cotinine
             &gt;100ng/ml (as measured with NicAlert)

        Exclusion Criteria:

          1. Impaired mental status as assessed by observation

          2. Acute intoxication as measured by breath alcohol level (BAL) &gt; 0

          3. Current use of nicotine replacement or other pharmacotherapy for smoking cessation

          4. Previous use of e-cigarettes

          5. Use of other tobacco products (e.g., chew tobacco, cigars) on &gt; 10 of the past 30 days

          6. Unstable HIV or associated comorbidities, as determined by a licensed medical
             professional.

          7. Pregnancy (Females testing positive for pregnancy and any participants wishing to quit
             immediately will be referred to community smoking cessation treatment and will be
             excluded from the study)

          8. Blood pressure at or above 160/100 or below 90/50

          9. Heart rate at or above 105 bpm or below 45 bpm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>F. Joseph McClernon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lauren Pacek, PhD</last_name>
    <phone>9196845437</phone>
    <email>lauren.pacek@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University School of Medicine</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27707</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Pacek, PhD</last_name>
      <phone>919-684-5437</phone>
      <email>lauren.pacek@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2015</study_first_submitted>
  <study_first_submitted_qc>November 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2015</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

